147 related articles for article (PubMed ID: 15743510)
1. Clinical trial update: National Cancer Institute of Canada.
Pritchard K; Whelan T
Breast Cancer Res; 2005; 7(2):48-51. PubMed ID: 15743510
[TBL] [Abstract][Full Text] [Related]
2. Clinical cooperative trials of the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
Pritchard KI
Cancer; 1994 Aug; 74(3 Suppl):1150-5. PubMed ID: 8039151
[TBL] [Abstract][Full Text] [Related]
3. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
Wolff AC; Davidson NE
J Clin Oncol; 2006 Nov; 24(31):4949-51. PubMed ID: 17075110
[No Abstract] [Full Text] [Related]
4. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
Parulekar WR; Day AG; Ottaway JA; Shepherd LE; Trudeau ME; Bramwell V; Levine M; Pritchard KI;
J Clin Oncol; 2005 Sep; 23(25):6002-8. PubMed ID: 16135468
[TBL] [Abstract][Full Text] [Related]
6. [Radiation and concomitant chemotherapy after surgery for breast cancer].
Calais G
Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant systemic therapy for early breast cancer: progress and controversies.
Hortobagyi GN
Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
[No Abstract] [Full Text] [Related]
8. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute.
Valagussa P; Bonadonna G
Zentralbl Gynakol; 1996; 118(10):571. PubMed ID: 8912477
[No Abstract] [Full Text] [Related]
9. [Sequencing of adjuvant treatment after surgery for invasive breast cancer].
Petit T; Claude L; Carrie C
Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202
[TBL] [Abstract][Full Text] [Related]
10. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
Sdrobolini A
Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
[No Abstract] [Full Text] [Related]
11. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
Azria D; Lemanski C; Zouhair A; Gutowski M; Belkacémi Y; Dubois JB; Romieu G; Ozsahin M
Cancer Radiother; 2004 Jun; 8(3):188-96. PubMed ID: 15217586
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant and neoadjuvant therapy for gastric cancer.
Kelsen DP
Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
[TBL] [Abstract][Full Text] [Related]
14. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Kunkler I
J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
[No Abstract] [Full Text] [Related]
15. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
Newman LA; Mamounas EP
Surg Clin North Am; 2007 Apr; 87(2):279-305, vii. PubMed ID: 17498527
[TBL] [Abstract][Full Text] [Related]
16. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P
Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082
[TBL] [Abstract][Full Text] [Related]
17. Late effects of adjuvant therapy for breast cancer.
Shapiro CL; Recht A
J Natl Cancer Inst Monogr; 1994; (16):101-12. PubMed ID: 7999452
[No Abstract] [Full Text] [Related]
18. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
[No Abstract] [Full Text] [Related]
19. Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.
Ng R; Hasan B; Mittmann N; Florescu M; Shepherd FA; Ding K; Butts CA; Cormier Y; Darling G; Goss GD; Inculet R; Seymour L; Winton TL; Evans WK; Leighl NB; ; ;
J Clin Oncol; 2007 Jun; 25(16):2256-61. PubMed ID: 17538170
[TBL] [Abstract][Full Text] [Related]
20. Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.
Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba PF; Chiesa F; Di Leone A; Masetti R
Eur Rev Med Pharmacol Sci; 2007; 11(5):283-9. PubMed ID: 18074936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
